BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24098737)

  • 21. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
    Fan X; Bjerke GA; Riemondy K; Wang L; Yi R
    Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.
    Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
    World J Gastroenterol; 2016 Jun; 22(24):5532-9. PubMed ID: 27350731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells.
    Wu W; Yang J; Feng X; Wang H; Ye S; Yang P; Tan W; Wei G; Zhou Y
    Mol Cancer; 2013 Apr; 12():30. PubMed ID: 23617834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5.
    Zhu L; Zhu Q; Wen H; Huang X; Zheng G
    J Cell Physiol; 2019 Jun; 234(6):8928-8940. PubMed ID: 30317620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway.
    Huang Z; Xing S; Liu M; Deng W; Wang Y; Huang Z; Huang Y; Huang X; Wu C; Guo X; Pan X; Jiang J; Feng F; Li T
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
    Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
    Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
    Zhu L; Wang X; Wang T; Zhu W; Zhou X
    Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21.
    Zhou B; Wang J; Zheng G; Qiu Z
    Food Chem Toxicol; 2016 Nov; 97():375-384. PubMed ID: 27725205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High miR-718 Suppresses Phosphatase and Tensin Homolog (PTEN) Expression and Correlates to Unfavorable Prognosis in Gastric Cancer.
    Liu S; Tian Y; Zhu C; Yang X; Sun Q
    Med Sci Monit; 2018 Aug; 24():5840-5850. PubMed ID: 30131483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.
    Wang M; Qiu R; Gong Z; Zhao X; Wang T; Zhou L; Lu W; Shen B; Zhu W; Xu W
    J Cell Biochem; 2019 Sep; 120(9):15027-15037. PubMed ID: 31009138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.
    Palumbo T; Faucz FR; Azevedo M; Xekouki P; Iliopoulos D; Stratakis CA
    Oncogene; 2013 Mar; 32(13):1651-9. PubMed ID: 22614013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-130b can suppress proliferation of glioma cells through targeting PTEN to regulate AKT pathway.
    Niu H; Liu Y; Wang Y; Tian Y; Jiang H; Cao S; Yang M; Li S
    J BUON; 2020; 25(4):2059-2065. PubMed ID: 33099953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.
    Ottman R; Levy J; Grizzle WE; Chakrabarti R
    Oncotarget; 2016 Nov; 7(45):73739-73753. PubMed ID: 27650539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.